The conflicting results regarding CXCL14 expression in CRC may be due to differences in the definition of control tissue, assessment methods (RT-qPCR vs. IHC scoring), tumor heterogeneity, and the dual biological role of CXCL14 (tumor suppressor vs. tumor promoter). The gene discussed is CXCL14; the disease is colorectal carcinoma.